Abstract
The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma (Candida) auris is a subject of speculation, with hypotheses including avian species and marine environments. Interestingly, yeasts related to Candidozyma auris have been repeatedly observed associated with various insects. This prompted us to investigate a thermophilic insect, Locustana pardalina, as a possible host for C. auris. Here, we report the isolation and identification of three C. auris strains from the gut of L. pardalina as well as the phenotypic characterisation of one of these isolates. Interestingly, the isolate was able to survive at 50°C and grew at 15% NaCl. In addition, it was susceptible to the tested disinfectants and antifungals, except fluconazole. Genome sequencing and single-nucleotide polymorphism analyses placed the isolate in Clade III, which is common in South African hospitals. This highlights the potential role of thermotolerant insects in the evolution and dissemination of emerging pathogenic yeasts.
Keywords: Candidozyma (Candida) auris, Locustana pardalina, environmental niche, fluconazole, disinfectants, stress tolerance, One Health
Introduction
Candida auris, an emerging pathogenic yeast that is able to cause nosocomial outbreaks, forms part of a clade of closely related species, consisting of Candida auris, Candida duobushaemuli (also known as C. duobushaemulonii), Candida haemuli (also known as C. haemulonii), Candida haemuli var. vulneris, Candida heveicola, Candida khanbhai, Candida konsanensis, Candida metrosideri, Candida ohialehuae, Candida pseudohaemuli (also known as C. pseudohaemulonii), Candida ruelliae, and Candida vulturna in the Metschnikowiaceae. This classification has recently been revised, and these species have been reassigned to the new genus Candidozyma. The updated nomenclature will be used here. Many of these species can cause human infections and are resistant to antifungal drugs.1
One of the unanswered questions regarding the emergence of Candidozyma auris is its environmental niche and mode of transmission from the environment to humans. It has been hypothesised that this yeast might have intermediate hosts, such as birds, which could facilitate its spread and transmission to humans.2 This is speculated to be due to the high body temperature of birds that would allow colonisation or infection only by thermophilic yeasts able to grow at > 40°C, allowing their spread via migratory birds to different geographic locations. However, no evidence is available regarding direct isolation of C. auris or the presence of its DNA from birds.3,4
Interestingly, members of Candidozyma are associated with insects, which may act as vectors of these yeasts. Strains of C. duobushaemuli have been isolated from the European firebug (Pyrrhocoris apterus)5, and its DNA has been detected in microbiomes from the Asian tiger mosquito (Aedes albopictus). Similarly, DNA sequences of C. haemuli were present in Svensson's copper underwing (Amphipyra berbera), the cosmopolitan springtail (Entomobrya nivalis), double-spined bark beetle (Ips duplicatus), six-toothed bark beetle (Ips sexdentatus), slender springtail (Orchesella flavescens), and longhorn crazy ant (Paratrechina longicornis). In addition, sequences of C. haemuli, C. haemuli var. vulneris, and C. duobushaemuli were abundant in microbiomes of termites (Isoptera spp.), while DNA sequences of C. heveicola were detected in samples from the gut of the Julia butterfly (Dryas iulia), the ghost yellow butterfly (Eurema albula), and the spot-banded daggerwing (Marpesia merops).4 This insect association prompted us to investigate the presence of C. auris (a known thermotolerant yeast) in insects that can withstand high temperatures.
An example of a group of cosmopolitan insects with a high body temperature preference is locusts. Migratory locusts (Locusta migratoria) have a preferred body temperature of 38–39°C if food is abundant6, although lower temperatures are selected when food becomes limiting.7 The desert locust (Schistocerca gregaria) can tolerate 50°C without apparent adverse effects.8 Similarly, the brown locust (Locustana pardalina) is typically exposed to high ambient temperatures of 33–38°C, soil temperatures of 39–62°C, and is reported to have a preferred body temperature of 39–41°C.9 Thus, we investigated the presence of C. auris in adult L. pardalina in South Africa.
Materials and methods
Collection of Locustana pardalina
Twenty gregarious (swarming) adult locusts were collected by sweep net on 16 April, 2022, during a large locust outbreak, which occurred from September 2021 to May 2022. The coordinates of the sample site are 31°58'45.99‘S and 24°42'7.58’E, within the semi-arid Eastern Karoo climactic region in the Eastern Cape of South Africa. This is a remote rural area, consisting mostly of large private grazing farms with minimal human occupation.
Yeast isolation from the alimentary canal of brown locust
The locusts were surface sterilised, and the entire alimentary canal was removed and dissected into the fore-, mid-, and hindgut. Each section was vigorously rinsed in sterile distilled water. This rinse water was plated onto Yeast Malt Extract (YM) agar (3 g/l malt extract, 3 g/l yeast extract, 5 g/l peptone powder, 10 g/l d-glucose, and 16 g/l agar) and incubated at 30°C. Colonies with different characteristics were sub-cultured until pure cultures were obtained.
Identification of isolated strains
All the pure colonies were cultured in YM broth at 37°C overnight while shaking. Two ml of the culture was concentrated using centrifugation (Centrifuge 5430R Eppendorf® USA: F—35–6—30 rotor) and was resuspended in 200 µl of Phosphate Saline Buffer. The complete 200 µl of resuspended cells was used to extract genomic DNA (gDNA) using the protocol stipulated in the ZYMO Research Quick DNA TM Fungal/Bacterial Miniprep Kit (ZymoResearch, USA). gDNA extraction was confirmed using gel electrophoresis (0.8% agarose gel at 90 V, 400 mA for 25 min).
Both the ITS region and the D1/D2 domains of the LSU rRNA gene were amplified by polymerase chain reaction (PCR) using the respective primer pairs of ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) and ITS5 (5’-GGAAGTAAAAGTCGTAACAAGG-3’) as well as NL1 (5′-GCATATCAATAAGCGGAGGAAAAG-3′) and NL4 (5′-GGTCCGTGTTTCAAGACGG-3′), according to Kurtzman and Robnett.10 Following amplicon clean-up and post-clean-up PCR, amplicons were sequenced using the BigDyeTM Terminator Sequencing kit on the Applied Biosystems 3500 genetic analyser. Consensus sequences obtained for each isolate were compared to the GenBank nucleotide data library using the Basic Local Alignment Search Tool (BLAST) software11 at the National Centre for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov).
All strains were deposited in the Biodiversity Biobanks South Africa Yeast culture collection, held at the Department of Microbiology and Biochemistry, University of the Free State, and preserved in glycerol stocks at -80°C. Only one of the identified C. auris strains (UOFS Y-4024) could be revived from cryostorage and was further characterised.
Genomic characterisation
Extracted gDNA was quantified using the Qubit 4 Fluorometer with the Qubit™ dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). Paired-end library (2 × 150 bp) was prepared using Illumina DNA Prep kit (Illumina, San Diego, US), followed by sequencing on an Element Biosciences Aviti™ Sequencer using Cloudbreak Freestyle chemistry kit (Element Biosciences, San Diego, CA, USA) with 100X coverage.
Raw sequencing reads of C. auris UOFS Y-4024 were processed using the v1.5 mycoSNP12 Nextflow (v23.10.0) nf-core13 pipeline. The Centre for Disease Control C. auris reference genome (GCA_016772135.1_ASM1677213v1_genomic.fna) was used for alignment and single-nucleotide polymorphism (SNP) identification. In addition to the study isolates, sequence reads were obtained from the NCBI Sequence Read Archive (SRA) for a total of 32 publicly available C. auris genomes from Clades I to VI based on clade-level classification by Suphavilai and co-workers14 and included for phylogenetic analyses (Supplementary Table S1). Briefly, (i) the mycoSNP pipeline prepared the reference genome for alignment with nucmer, samtools, Picard tools, and BWA index and (ii) sample QC was assessed with FastQC15, poor quality sequence data were trimmed with FaQCS v 2.10 and SeqKit, trimmed sequence reads were aligned to the reference with Burrows-Wheeler Aligner- Maximum Exact Matches (BWA-MEM) (v0.7.17), and alignment file filtering with Picard (http://broadinstitute.github.io/picard/). The GATK4 pipeline (v4.2.5.0) was used for variant calling and to generate a multi-fasta from a combined variant calling file using Bcftools (v1.14), and finally phylogenetic trees were drawn using fasttree (v2.1.10), quicksnp (v1.0.1) (https://github.com/k-florek/QuickSNP), iqtree (v2.1.4), and rapidnj (v2.3.2).15–24
The genome of UOFS Y-4024 was assembled using SPAdes genome assembler (v3.14.1) with default parameters. Quality metrics for the assembly were assessed using QUAST (v5.0.2)25, and completeness was evaluated with Benchmarking Universal Single-Copy Orthologs (BUSCO) using the fungal_odb10 dataset.26 To annotate the assembly, gene features were transferred from the C. auris Clade III reference genome GCF_003013715.1 using Liftoff (v1.6.3).27 Transcripts were extracted and translated into proteins using SeqKit (v2.2.0).19 In order to determine the mating-type, proteins from LGST01000043.1 were queried against the assembly using tBLASTn (v2.10.1+),28 and alignment results were inspected for order and orientation.
Phylogenetic placement within Clade III
To contextualise UOFS Y-4024 within Clade III of C. auris, SRA data corresponding to 566 Clade III genomes—previously curated by Cancino-Muñoz and co-workers29 were obtained from NCBI. A core-genome SNP alignment was generated using SNIPPY (v4.6.0), using the Clade III reference strain B11221 (accession CP126632.2) as the reference genome. Repetitive and low-complexity regions were identified using RepeatMasker (v4.1.6) and masked using the remove_blocks_from_aln.py script from the Sanger Institute (https://github.com/sanger-pathogens/remove_blocks_from_aln). Phylogenetic reconstruction was performed with Gubbins using RAxML (model GTRGAMMA, 200 bootstrap replicates).30
Antifungal resistance marker identification
To identify well-known resistance-associated genes/proteins, the proteome of isolate UOFS Y-4024 was queried with protein sequences ERG11 (XP_716761.1) and FKS1 (XP_028893355.2) using BLASTp (v2.10.1+).28 Additionally, the predicted proteome was scanned with HMMER3’s hmmscan tool (v3.3.1) against the ResFungi database of fungal resistance profiles compiled by de Carvalho and co-workers.31
Salt tolerance determination
C. auris UOFS Y-4024 was inoculated into 5 ml Yeast Potato Dextrose (YPD) media (10 g/l yeast extract, 20 g/l peptone, and 20 g/l d-glucose) and incubated for 24 h at 37°C while shaking. A 10x cell dilution was prepared with YPD media, and the OD600 was measured with a Jenway 6400 spectrophotometer. Cells were standardised to an OD600 of 0.8. A 10X serial dilution series was prepared for the standardised cells, and 10 µl of the 10-1 to 10-4 dilutions were spotted onto prewarmed YPD plates supplemented with NaCl concentrations of 0%, 10%, 15%, and 20%. These plates were incubated at 37°C for 72 h. C. auris B11221 (Clade III) and Candida albicans SC5314 were included as control strains.
Temperature tolerance determination
C. auris UOFS Y-4024 was grown and standardised to an OD600 of 0.8, and 200 µl of the standardised cells were plated into a 96-well plate with YPD negative controls. Growth at 30°C, 40°C, and 50°C was monitored for 24 h in a Victor Nivo plate reader. This was done in triplicate and each 96-well plate contained five technical repeats.
Antifungal susceptibility testing
Antifungal susceptibility, determined by the minimum inhibitory concentration (MIC), was assessed using the AST-YS08 card on the Vitek 2 Compact system (Biomerieux, France), in accordance with the manufacturer's guidelines. The antifungal panel included fluconazole, voriconazole, caspofungin, micafungin, amphotericin B, and flucytosine. Tentative breakpoints as suggested by the Centers for Disease Control and Prevention (CDC) were used in the interpretation of MIC obtained.
Disinfectant susceptibility testing
C. auris UOFS Y-4024 was grown in YPD at 37°C overnight while shaking and standardised to 106 cells/ml. A 2x serial dilution of each disinfectant was prepared in 2x RPMI-1640 of in a 96-well plate. Cells were then exposed to the disinfectant for 20 min and reinoculated in 2x RPMI-1640 to determine MIC values. The disinfectants used were absolute ethanol and commercial preparations containing either 10% povidone iodine, 3.5% sodium hypochlorite, 12% polydimethylammonium chloride, 80% didecyldimethylammonium chloride, 50% benzalkonium chloride, 5% chlorhexidine gluconate, or a combination of 0.5% chlorhexidine gluconate and 70% isopropyl alcohol.
Results
Three C. auris strains were isolated from three different adult locusts, two of which also harboured Candida orthopsilosis strains (Table 1). We were able to revive one of the C. auris strains (17C2 = UOFS Y-4024) from cryostorage, and genotypic and phenotypic analyses were performed on this strain. This strain was also deposited in the Westerdijk Fungal Biodiversity Institute as CBS 19369.
Table 1.
Potentially pathogenic yeasts isolated from the alimentary canal of Locustana paradalina.
| Strain number | Species name | Isolated from |
|---|---|---|
| 2A2 | Candidozyma (Candida) auris | Locust #2 foregut |
| 2B1 | Candida orthopsilosis | Locust #2 midgut |
| 15C2 | Candidozyma (Candida) auris | Locust #15 hindgut |
| 15B1 | Candida orthopsilosis | Locust #15 midgut |
| 17C2 UOFS Y-4024 |
Candidozyma (Candida) auris | Locust #17 hindgut |
Assembly of C. auris UOFS Y-4024 using short-read data and SPAdes default parameters, produced a genome with a total length of 12 369,881 bp across 109 contigs larger than 200 bp, with the largest contig measuring 2 893 009 bp and an N50 of 1 075 510 bp. Assessment of genome completeness using BUSCO indicated 48 missing BUSCOs (Table 2), compared to 58 missing in the Clade III reference genome B11221. These results suggest comparable completeness between the de novo assembly and the established reference. The whole genome sequence was deposited in NCBI BioProject database (BioProject ID: PRJNA1214514).
Table 2.
Genome assembly quality metrics and other characteristics.
| Assembly metrics | Value |
|---|---|
| Contigs > 200bp | 109 |
| Total length in bp (contigs > 200 bp) | 12 369 881 |
| Largest Contig | 2 893 009 |
| N50 | 1 075 510 |
| L50 | 4 |
| GC (%) | 45.15 |
| N's per 100 000 bp | 2.42 |
| Complete BUSCOs | 706 (93.1%) |
| Fragmented BUSCOs | 4 (0.5%) |
| Missing BUSCOs | 48 (6.4%) |
Phylogenetic placement of UOFS Y-4024 amongst 566 clade III isolates identified the most-closely related strains to have been isolated from South African clinical specimens and sequenced between 2012 and 201432 (Fig. 1). The order and orientation of mating-locus genes were in accordance with a Matα conformation, which is the most common conformation amongst Clade III strains.33 The tree file is available at https://figshare.com/articles/dataset/Phylogenetic_Tree_File/29222603?file=55075763.
Figure 1.
Global phylogeny of all Clade III Candidozyma auris isolates analysed (n = 566). Coloured nodes indicate the origin country: yellow—Australia; light blue—Austria; black—Canada; orange—China; brown—Kenya; green—South Africa; red—Spain; purple—United Kingdom; and blue—United States.
From the genome sequence, FKS1 was identified as wild-type, while ERG11 carried the V125A/F126L substitution. Phenotypic characterisation and interpretation according to CDC tentative breakpoints confirmed that C. auris UOFS Y-4024 is resistant to fluconazole, with an MIC of ≥32 µg/ml. This is also significantly higher than the ≥4 µg/ml point that may indicate fluconazole resistance in C. auris as determined by Vitek 2.34 Interestingly, although 63 putative resistance markers to 5-fluorocytosine, azoles, caspofungin, fluconazole, itraconazole, micafungin and voriconazole were identified through ResFungi HMM scanning (Supplementary Table S1), this strain was susceptible to the other antifungals tested (Table 3). The isolate was also evaluated against disinfectants from multiple classes and found to be inhibited by all of them at concentrations lower than the recommended use concentration, including a range of quaternary ammonium compounds (QACs) (Table 4). C. auris UOFS Y-4024 is halotolerant and can grow on 15% NaCl (Fig. 2) and grows faster at 40°C, with a µmax of 0.061h-1 after 120 min, compared to 30°C, where a lower µmax of 0.044h-1 was obtained after 210 min. Interestingly, it survived and grew slowly (µmax = 0.009h-1) at 50°C. This level of growth was attained after 210 min and maintained for an additional 240 min.
Table 3.
Minimum inhibitory concentrations (MICs) of antifungal drugs against C. auris UOFS Y-4024.
| Antifungal drug | Tentative breakpoints (µg/ml)a | MIC (µg/ml) |
|---|---|---|
| Fluconazole | ≥32 | 32 |
| Voriconazole | No breakpointb | 1 |
| Caspofungin | ≥2 | 0.25 |
| Micafungin | ≥4 | ≤0.06 |
| Amphotericin B | >2 | ≤0.25 |
| Flucytosine | No breakpoint | ≤1 |
Tentative breakpoints by the CDC (https://www.cdc.gov/candida-auris/hcp/laboratories/antifungal-susceptibility-testing.html).
Fluconazole is recommended as a surrogate.
Table 4.
Minimum inhibitory concentrations (MIC90) of disinfectants against C. auris UOFS Y-4024 after 20 min contact time.
| Active compound | MIC90 (% final concentration of active compound) | Recommended use concentration of active compound (%) | MIC90 ≥ recommended use concentration |
|---|---|---|---|
| Ethanol | 29.5 | 60–80 | No |
| 10% povidone iodine | 0.096 | 5–10 | No |
| 3.5% sodium hypochlorite | 0.24 | 0.1–0.5 | No |
| 12% polydimethylammonium chloride | 0.006 | 0.1–0.5 | No |
| 80% didecyldimethylammonium chloride | 0.0012 | 0.05-0.2 | No |
| 50% benzalkonium chloride | 0.003 | 0.05–0.2 | No |
| 0.05% chlorhexidine gluconate | 0.0015 | 0.5–2 | No |
| 0.5% chlorhexidine gluconate combined with 70% ethanol | 0.0125 chlorhexidine gluconate0.175 ethanol | 0.5–2 chlorhexidine gluconate60%–80% ethanol | No |
Figure 2.
Growth of C. auris UOFS Y-4024, C. auris B11221 and C. albicans SC5314 on media containing NaCl concentrations ranging from 0% to 20%.
Discussion
This study highlights for the first time the presence of C. auris in the digestive tract of the brown locusts, Locustana pardalina, and shows their potential in disseminating this emerging pathogen. The fact that we were able to isolate C. auris from three locusts (15% of locusts tested) using non-selective media and a non-restrictive temperature of 30°C may indicate that C. auris is abundant in the locusts and that specific selective isolation is not mandatory.
Interestingly, although C. orthopsilosis was only isolated from the midgut, C. auris was isolated from the fore- and hindgut. Isolation from the foregut, which is dedicated to food intake and storage, filtering, and partial digestion, indicates that C. auris was probably obtained by the locusts via feeding activities. Isolation from the hindgut confirms that C. auris can survive the digestive processes in the midgut and is likely to be released back into the environment via frass (faeces).35 As indicated, L. pardalina is typically exposed to high temperatures and has a preferred body temperature of 39–41°C.9 Locusts (Schistocerca or Locusta spp.) also require between 1 and 2% salts in their diet and can tolerate excess salts (up to 11%) and wide variations in the ratios of ions in the diet.36Locustana pardalina hoppers are also attracted to NaCl and NaH2PO4, which may be consumed, possibly to alleviate mineral deficiencies in their grass diet.37 Thus, the ability of C. auris UOFS Y-4024 to grow under high salt concentration and high temperatures correlates with the environmental and physiological tolerance of locusts. Although the soil and groundwater in the area where the locusts were collected are not particularly high in sodium salts and are considered slightly saline (200–400 mS/m),38,39L. pardalina can travel up to 2.8 km per day (depending on the instar), while the flying adults can cross large distances.9 It is unknown how far they may have migrated during their swarming behaviour or where they may have ingested the yeasts isolated from them. The fact that this strain belongs to Clade III and is closely related to clinical isolates obtained from patients more than a decade ago raises interesting questions regarding the ecology and epidemiology of C. auris in South Africa. This and other studies40 highlight the importance of insects as potential vectors for the distribution of pathogenic yeasts.
The decreased susceptibility to fluconazole is a common feature of many C. auris strains, including ones from non-clinical environments. For example, a C. auris strain isolated from an Egyptian cobra from a Moroccan market (also a hot, arid environment) was also considered fluconazole resistant.41 Currently, no standards or recommended methods exist to eradicate C. auris from contaminated surfaces and infected individuals. Previously, ethanol has been shown to be effective against C. auris at a concentration of 70%42, and our results support this finding as the MIC90 determined was 29.5%. Similarly, povidone iodine at a final concentration of 0.096% effectively inhibited growth of C. auris UOFS Y-4024. This is similar to findings by Abdolrasouli and co-workers43, who reported MICs between 0.07% and 1.25%. The growth of C. auris UOFS Y-4024 was also inhibited by 0.24% sodium hypochlorite. Interestingly, disinfectants containing 0.05% sodium hypochlorite are effective against Clade I C. auris but not Clade IV.44 We also found that chlorhexidine, either alone or combined with ethanol, is able to inhibit growth of C. auris UOFS Y-4024 at concentrations below the recommended use concentrations.42,45,46 Different QACs were also tested and found to be very effective at low concentrations. This observed sensitivity to QACs is interesting, as many studies have indicated that C. auris is not susceptible to this class of compound.44,47,48 However, it is known that contact time may influence the effect of different disinfectants47, making it difficult to compare results between studies. The use of 20 min of contact time in our study may have decreased the MICs compared to those reported in literature. The sensitivity to a range of disinfectants, including ethanol and QACs, enables practical approaches to containment, although the possibility of acquired resistance to these disinfectants is concerning.
In conclusion, the ability of C. auris to survive various environmental and chemical stressors in the digestive system of locusts highlights the importance of understanding the interaction between insects and pathogenic yeasts and the possible role of insects in the emergence of new pathogenic yeasts under different ecological regimes. This One Health approach is especially important as locusts (and other insects) are often harvested as food source in many parts of the world (Fig. 3).
Figure 3.
Bag of locusts for sale as food in a market in Nigeria.
Supplementary Material
Supplementary Table S1. List of genomes with Clade designation and Sequence Read Archive identifications used for initial phylogenetic analyses.
Acknowledgement
Tha authors wish to acknowledge Dr Sunday Ayuba Buru for providing the photo for Figure 3.
Contributor Information
Adepemi Ogundeji, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Maryam Bello-Akinosho, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Vaughn Swart, Department of Zoology and Entomology, University of the Free State, Bloemfontein, 9301, South Africa.
Jonathan Featherston, Sequencing Core Facility, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Sandringham, 2192, South Africa.
Errol D Cason, Department of Animal Sciences, University of the Free State, Bloemfontein, 9301, South Africa.
Armand Bolsenbroek, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Carel Beneke, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Jolly Musoke, Department of Medical Microbiology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, 9301, South Africa; National Health Laboratory Service, Department of Medical Microbiology, Universitas Academic Hospital, Bloemfontein, 9301, South Africa.
Tyla Baker, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Arshad Ismail, Sequencing Core Facility, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Sandringham, 2192, South Africa; Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Thohoyandou, 0950, South Africa.
Olihile Sebolai, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Jacobus Albertyn, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Carolina Pohl, Department of Microbiology and Biochemistry, University of the Free State, Bloemfontein, 9301, South Africa.
Author contribution
Adepemi Ogundeji (Investigation, Writing—original draft), Maryam Bello-Akinosho (Investigation, Writing—original draft), Vaughn Swart (Investigation, Resources, Writing—original draft), Jonathan Featherston (Formal analysis, Investigation, Writing—original draft), Errol D. Cason (Formal analysis, Visualization, Writing—review & editing), Armand Bolsenbroek (Investigation, Visualization, Writing—original draft), Carel Beneke (Investigation, Writing—original draft), Jolly Musoke (Investigation, Resources), Tyla Baker (Investigation, Writing—original draft), Arshad Ismail (Resources, Supervision), Olihile Sebolai (Resources, Supervision), Jacobus Albertyn (Formal analysis, Resources, Supervision), and Carolina Pohl (Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing—review & editing).
Funding
This study was funded by the National Research Foundation of South Africa (https://www.nrf.ac.za/), under the Foundational Biodiversity Information Small Grant Programme (grant number FBIS2204062196) to CHP. The funders played no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.
Declaration of interest
The authors have no relevant financial or non-financial interests to disclose.
Data availability
The whole genome sequence assembly of Candida auris UOFS Y-4024, has been deposited in the NCBI BioProject database under the accession number PRJNA1214514. The complete list of publicly available Sequence Read Archive (SRA) data for the 566 Clade III genomes retrieved from NCBI is as published33 and available in Supplementary Table S1. The phylogenetic tree file generated from these data is available at Figshare: https://figshare.com/articles/dataset/Phylogenetic_Tree_File/29222603?file=55075763.
References
- 1. Liu F, Hu Z-D, Zhao X-M et al. Phylogenomic analysis of the Candida auris-Candida haemuli clade and related taxa in the Metschnikowiaceae , and proposal of thirteen new genera, fifty-five new combinations and nine new species. Persoonia-Mol Phylog Evol Fungi. 2024; 52: 22–43. 10.3767/persoonia.2024.52.02 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: Climate change, azoles, swamps, and birds. mBio. 2019; 10: e01397–19. doi: 10.1128/mBio.01397-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Akinbobola AB, Kean R, Hanfi SMA, Quilliam RS. Environmental reservoirs of the drug-resistant pathogenic yeast Candida auris. PLoS Pathog. 2023; 19: e1011268. 10.1371/journal.ppat.1011268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Irinyi L, Roper M, Malik R, Meyer W. In silico environmental sampling of emerging fungal pathogens via big data analysis. Fungal Ecol. 2023; 62: 101212. 10.1016/j.funeco.2022.101212 [DOI] [Google Scholar]
- 5. Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A et al. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. Vulnera var. nov.: Three multiresistant human pathogenic yeasts. J. Clin. Microbiol. 2012; 50: 3641–3651. 10.1128/jcm.02248-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Miller GA, Clissold FJ, Mayntz D, Simpson SJ. Speed over efficiency: Locusts select body temperatures that favour growth rate over efficient nutrient utilization. Proc Royal Soc B: Biol Sci. 2009; 276: 3581–3589. 10.1098/rspb.2009.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Coggan N, Clissold FJ, Simpson SJ. Locusts use dynamic thermoregulatory behaviour to optimize nutritional outcomes. Proc Royal Soc B: Biol Sci. 2011; 278: 2745–2752. 10.1098/rspb.2010.2675 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Maeno KO, Ely SO, Mohamed SO, Javaar MEH, Ebbe MOAB. Thermoregulatory behavior of lekking male desert locusts, Schistocerca gregaria, in the Sahara Desert. J Therm Biol. 2023; 112: 103466. 10.1016/j.jtherbio.2023.103466 [DOI] [PubMed] [Google Scholar]
- 9. Duncan FD, Hanrahan SA. Respiratory patterns in field collected brown locust, Locustana pardalina, in the gregarious phase. J Insect Physiol. 2018; 106: 209–216. 10.1016/j.jinsphys.2018.01.004 [DOI] [PubMed] [Google Scholar]
- 10. Kurtzman CP, Robnett CJ. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie Leeuwenhoek. 1998; 73: 331–371. 10.1023/a:1001761008817 [DOI] [PubMed] [Google Scholar]
- 11. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990; 215: 403–410. 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
- 12. Bagal UR, Phan J, Welsh RM et al. MycoSNP: A portable workflow for performing whole-genome sequencing analysis of Candida auris. Methods Mol. Biol. 2022; 2517: 215–228. 10.1007/978-1-0716-2417-3_17. [DOI] [PubMed] [Google Scholar]
- 13. Ewels PA, Peltzer A, Fillinger S et al. The nf-core framework for community-curated bioinformatics pipelines. Nature Biotech. 2020; 38: 276–278. 10.1038/s41587-020-0439-x [DOI] [PubMed] [Google Scholar]
- 14. Suphavilai C, Ko K, Tan MG, Lim KM, Nagarajan N. Detection and characterisation of a sixth Candida auris clade in Singapore: A genomic and phenotypic study. Lancet Microbe. 2024; 5: e103466. 10.1016/S2666-5247(24)00101-0 [DOI] [PubMed] [Google Scholar]
- 15. Andrews S. FastQC: A quality control tool for high throughput sequence data. In: Babraham Bioinformatics. Cambridge, United Kingdom: Babraham Institute, 2010. Accessed 23 March, 2025. https://www.bioinformatics.babraham.ac.uk/projects/fastqc/. [Google Scholar]
- 16. Kurtz S, Phillippy A, Delcher AL et al. Versatile and open software for comparing large genomes. Genome Biol. 2004; 5: R12. 10.1186/gb-2004-5-2-r12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Li H, Handsaker B, Wysoker A et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009; 25: 2078–2079. 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Lo CC, Chain PSG. Rapid evaluation and quality control of next generation sequencing data with FaQCs. BMC Bioinf. 2014; 15: 366. 10.1186/s12859-014-0366-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Shen W, Le S, Li Y, Hu F. SeqKit: A cross-platform and ultrafast toolkit for FASTA/Q file manipulation. PLoS One. 2016; 11: e0163962. 10.1371/journal.pone.0163962 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Van der Auwera GA, O'Connor BD. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra, O'Reilly Media. 2020.
- 21. Danecek P, Bonfield JK, Liddle J et al. Twelve years of SAMtools and BCFtools. GigaScience. 2021; 10: giab008. 10.1093/gigascience/giab008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Price MN, Dehal PS, Arkin AP. FastTree 2—Approximately maximum-likelihood trees for large alignments. PLoS One. 2010; 5: e9490. 10.1371/journal.pone.0009490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015; 32: 268–274. 10.1093/molbev/msu300 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Simonsen M, Mailund T, Pedersen CN. Rapid neighbour-joining. In: Crandall KA, Lagergren J, eds., Algorithms in Bioinformatics. WABI 2008. Lecture Notes in Computer Science, volume 5251. Berlin: Springer, 2008: 306–317. 10.1007/978-3-540-87361-7_26 [DOI] [Google Scholar]
- 25. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: Quality assessment tool for genome assemblies. Bioinformatics.2013; 29: 1072–1075. 10.1093/bioinformatics/btt086 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Manni M, Berkeley MR, Seppey M, Simão FA, Zdobnov EM. BUSCO Update: Novel and streamlined workflows along with broader and deeper phylogenetic coverage for scoring of eukaryotic, prokaryotic, and viral genomes. Mol Biol Evol. 2021; 38: 4647–4654. 10.1093/molbev/msab199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Shumate A, Salzberg SL. Liftoff: Accurate mapping of gene annotations. Bioinformatics. 2020; 37: 1639–1643. 10.1093/bioinformatics/btaa1016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Camacho C, Coulouris G, Avagyan V et al. BLAST+: Architecture and applications. BMC Bioinf. 2009; 10: 421. 10.1186/1471-2105-10-421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Cancino-Muñoz I, Mulet-Bayona JV, Salvador-García C et al. Short-term evolution and dispersal patterns of fluconazole-resistance in Candida auris clade III. mBio. 2025; 16: e0316424. 10.1128/mbio.03164-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Croucher NJ, Page AJ, Connor TR, Delane AJ, Keane JA, Bentley SD. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucl Acid Res. 2015; 43: e15. 10.1093/nar/gku1196 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. de Carvalho C, Bastos RW, Rossato L, de Aguiar Peres NT, Santos DA. ResFungi: A novel protein database of antifungal drug resistance genes using a hidden Markov model profile. ACS Omega. 2024; 9: 30559–30579. 10.1021/acsomega.4c02198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Lockhart SR, Etienne KA, Vallabhaneni S et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017; 64: 134–140. 10.1093/cid/ciw691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Muñoz JF, Gade L, Chow NA et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Comm. 2018; 9: 5346. 10.1038/s41467-018-07779-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Siopi M, Pachoulis I, Leventaki S et al. Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance. J Clin Microbiol. 2024; 62: e0152823. 10.1128/jcm.01528-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Stefanini I. Yeast-insect associations: It takes guts. Yeast. 2018; 35: 315–330. 10.1002/yea.3309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Dadd RH. The nutritional requirements of locusts—V: Observations on essential fatty acids, chlorophyll, nutritional salt mixtures, and the protein or amino acid components of synthetic diets. J Insect Physiol. 1961; 6: 126–145. 10.1016/0022-1910(61)90035-X [DOI] [Google Scholar]
- 37. Du Plessis C, Botha DH. Preliminary field experiments on the attractiveness of certain chemicals and bait carriers to the hoppers of the brown locust. J Entomol Soc SA. 1939; 2: 74–92.https://hdl.handle.net/10520/AJA00128789_3268 [Google Scholar]
- 38. Nell JP, Van Huyssteen CW. Geology and groundwater regions to quantify primary salinity, sodicity and alkalinity in South African soils. SA J Plant Soil. 2014; 31: 127–135. 10.1080/02571862.2014.921940 [DOI] [Google Scholar]
- 39. Nell JP. The influence of the soil formation factors on the mapping of salt-affected soils on a national scale in South Africa. In: Global Symposium on Salt Affected Soils. Rome, Italy: Food and Agriculture Organizations of the United Nations, 2021. Accessed 26 November, 2024. https://www.fao.org/fileadmin/user_upload/GSP/GSAS21/016.pdf. [Google Scholar]
- 40. Dimitrov R, Gouliamova D, Guéorguiev B, Smith M, Groenewald M, Boekhout T. First DNA barcoding survey in Bulgaria unveiled huge diversity of yeasts in insects. Insects. 2024; 15: 566. 10.3390/insects15080566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Cafarchia C, Mendoza-Roldan JA, Rhimi W et al. Candida auris from the Egyptian cobra: Role of snakes as potential reservoirs. Med Mycol. 2024; 62: myae056, 10.1093/mmy/myae056 [DOI] [PubMed] [Google Scholar]
- 42. Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Contr Hosp Epidemiol. 2019; 40: 380–382. 10.1017/ice.2019.1 [DOI] [PubMed] [Google Scholar]
- 43. Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017; 60: 758–763. 10.1111/myc.12699. [DOI] [PubMed] [Google Scholar]
- 44. Erganis S, Ozturk A, Uzuntas ST et al. Variable sensitivity of clinical Candida auris strains to biocides: Implications for infection control in healthcare settings. BMC Microbiol. 2024; 24: 447. 10.1186/s12866-024-03605-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Moore G, Schelenz S, Borman AM, Johnson EM, Brown CS. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect. 2017; 97: 371–375. 10.1016/j.jhin.2017.08.019 [DOI] [PubMed] [Google Scholar]
- 46. Johnson CJ, Eix EF, Lam BC et al. Augmenting the activity of chlorhexidine for decolonization of Candida auris from porcine skin. J Fungi. 2021; 7: 804. 10.3390/jof7100804 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Caceres DH, Forsberg K, Welsh RM et al. Candida auris: A review of recommendations for detection and control in healthcare settings. J Fungi. 2019; 5: 111. 10.3390/jof5040111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Voorn MG, Kelley AM, Chaggar GK, Li X, Teska PJ, Oliver HF. Contact time and disinfectant formulation significantly impact the efficacies of disinfectant towelettes against Candida auris on hard, non-porous surfaces. Sci Report. 2023; 13: 5849. 10.1038/s41598-023-32876-y [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Table S1. List of genomes with Clade designation and Sequence Read Archive identifications used for initial phylogenetic analyses.
Data Availability Statement
The whole genome sequence assembly of Candida auris UOFS Y-4024, has been deposited in the NCBI BioProject database under the accession number PRJNA1214514. The complete list of publicly available Sequence Read Archive (SRA) data for the 566 Clade III genomes retrieved from NCBI is as published33 and available in Supplementary Table S1. The phylogenetic tree file generated from these data is available at Figshare: https://figshare.com/articles/dataset/Phylogenetic_Tree_File/29222603?file=55075763.



